Brunel is a privately owned pharmaceutical business with a primary footprint in South Africa. Brunel has been servicing the pharmaceutical market for over forty years. Brunel’s business segments span across proprietary products which include pharmaceuticals and complementary medicines, dispensary consumables and certain distribution agreements.